Comparison of Translocator Protein Expression Between Tumefactive Multiple Sclerosis and Glioblastoma
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Accepteret manuskript, 658 KB, PDF-dokument
This figure presents a comparison of molecular imaging of the translocator protein (TSPO) and contrast-enhanced MRI in 2 patients with tumefactive multiple sclerosis and glioblastoma, respectively. In the case of the tumefactive multiple sclerosis patient, TSPO uptake is primarily located centrally, while in the glioblastoma patient, TSPO uptake is predominantly situated peripherally to the central necrotic area. These findings suggest that TSPO imaging could be a noninvasive imaging technique for distinguishing between these 2 diagnoses.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Nuclear Medicine |
Vol/bind | 48 |
Udgave nummer | 8 |
Sider (fra-til) | E403-E404 |
Antal sider | 2 |
ISSN | 0363-9762 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
Conflicts of interest and sources of funding: This work was financially supported by the European Union’s Seventh Framework Programme (FP7/2007-2013), the Danish Council for Independent Research, the Research Committee of Rigshospitalet, and Desirée and Niels Yde’s foundation. The authors have no conflicts to report.
Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
ID: 363282607